Android app Apple app link

Viking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past Month

By Yahoo! Finance   |   1 week ago
Viking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past Month

Viking Therapeutics saw an 11% monthly stock price decline amidst market downturns despite positive advancements like completing Phase 2 trials for VK2735 and securing a manufacturing agreement. The company's innovative treatments and strong pipeline signal promising future growth, potentially undervalued in the market.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.